Loss of normal kidney function affects more than 10% of the population and contributes to
morbidity and mortality. Kidney diseases are currently treated with immunosuppressive …

Preeclampsia is a common complication of pregnancy associated with high maternal
morbidity and mortality and intrauterine fetal growth restriction. There is extensive evidence …

There are many biological resources in nature that are essential in relation to health care.
Due to their flexible health benefits documented in various epidemiological studies, there …

BACKGROUND Pre-eclampsia has a clear familial component, suggesting that the condition
may be partly attributable to genetic susceptibility. The search for susceptibility genes has …

Preeclampsia is specific to pregnancy and is still a leading cause of maternal and perinatal
mortality and morbidity, affecting about 3% of women, but the underlying pathogenetic …

Since improving maternal and child health is a public health priority worldwide, the main aim
of treatment of hypertension in pregnant women is to prevent complications during …

Excess soluble fms-like tyrosine kinase 1 (sFlt-1) of vascular endothelial growth factor
receptor 1 secreted from the placenta causes pre-eclampsia–like features by antagonizing …

Preeclampsia and other hypertensive disorders of pregnancy are major contributors to
maternal morbidity and mortality worldwide. This group of disorders includes chronic …

Various hypotheses as to the origin of preeclampsia have been explored over time.
Diseases of pregnancy are difficult to study for several reasons. One limitation is due to the …

Endothelial NO, which is synthesized by endothelial nitric oxide synthase (eNOS), has been
reported to be related with the occurrence of pre-eclampsia (PE). However, the …